Quidel | Le Bénéfice D'Exploitation



Operating Profit Changement Date
Abbott USD 1.66B 253M 2025-03
Agilent USD 376M 32M 2025-01
Avanos Medical USD -418500000 430.5M 2024-12
Becton, Dickinson and Co. USD 546M 93M 2025-03
Bruker USD 64.1M 4M 2024-12
Charles River Laboratories USD -167687000 285.09M 2024-12
Danaher USD 1.28B 142M 2025-03
Exact Sciences USD -96010000 780.34M 2025-03
Haemonetics USD 59.03M 7.33M 2024-12
Hologic USD -7000000 236.8M 2025-03
Illumina USD 175M 566M 2024-12
IQVIA Holdings USD 626M 76M 2024-12
Merit Medical Systems USD 41.03M 4.47M 2025-03
Mettler Toledo International USD 201.94M 112.6M 2025-03
Myriad Genetics USD -39000000 19M 2024-12
Neogen USD 5.42M 462.9M 2025-02
Quidel USD -100400000 115.4M 2024-12
Revvity USD 72.23M 46.52M 2025-03
STAAR Surgical USD -27910000 33.59M 2024-12
Thermo Fisher Scientific USD 1.72B 300M 2025-03
Waters USD 292.26M 81.13M 2024-12



Quidel Le Bénéfice D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.